Pressemitteilung BoxID: 249547 (Nobel Biocare Deutschland GmbH)
- Nobel Biocare Deutschland GmbH
- Stolberger Straße 200
- 50933 Köln
- Süha Demokan
- +41 (43) 21142-30
Nobel Biocare receives positive ruling in its patent litigation with Materialise Dental in the US
(PresseBox) (Zurich, Switzerland, 23.03.09) Nobel Biocare has received a positive ruling in the U.S. Litigation with Materialise Dental in connection with the patent relating to NobelGuide. The Federal District Court in Santa Ana, California, has ruled that Nobel Biocare does not infringe any claim of Materialise's '134 patent related to NobelGuide. The products at issue in the lawsuit were the NobelGuide software and surgical templates. Materialise had claimed that Nobel Biocare's products infringed their patent, but the court has now ruled that the NobelGuide products are not covered by the Materialise patent. This ruling can be appealed. The German litigation between the parties is ongoing and a decision regarding Materialise's respective German patent is expected within the coming month(s).
Nobel Biocare Deutschland GmbH
Nobel Biocare is a medical devices group and the world leader in innovative esthetic dental solutions with its key brands NobelActive(TM) , Brånemark System®, NobelReplace(TM) , NobelSpeedy(TM) , Replace Select (dental implants), NobelProcera(TM) (individualized dental prosthetics), NobelGuide(TM) (complete patient rehabilitation program) and NobelSmile(TM) (patient education and awareness program). Nobel Biocare is a full solution provider for restorative esthetic dentistry, offering a wide range of innovative Crown & Bridge & Implant products, as well as training and education, patient information and clinically documented treatment concepts. Nobel Biocare has over 2,500 employees and recorded revenue of EUR 619.2 million in 2008. The Company is domiciled and headquartered in Zurich, Switzerland. Production takes place at six production sites located in Sweden, the US, Japan and Israel. Nobel Biocare has 37 direct sales organizations. The shares of the parent company Nobel Biocare Holding AG are listed on the SIX Swiss Exchange.